These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 17137250)

  • 1. [Molecular markers of head and neck cancer].
    Temam S; Janot F
    Rev Prat; 2006 Oct; 56(15):1658-61. PubMed ID: 17137250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New molecular diagnostic methods in head and neck cancer.
    Rodrigo JP; Ferlito A; Suárez C; Shaha AR; Silver CE; Devaney KO; Bradley PJ; Bocker JM; McLaren KM; Grénman R; Rinaldo A
    Head Neck; 2005 Nov; 27(11):995-1003. PubMed ID: 16200629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of molecular markers in the management of head and neck cancers.
    Ferreira MB; De Souza JA; Cohen EE
    Curr Opin Oncol; 2011 May; 23(3):259-64. PubMed ID: 21358329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of molecular markers and gene profiling in head and neck cancers.
    Gold KA; Kim ES
    Curr Opin Oncol; 2009 May; 21(3):206-11. PubMed ID: 19346943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular assays for the diagnosis of minimal residual head-and-neck cancer: methods, reliability, pitfalls, and solutions.
    van Houten VM; Tabor MP; van den Brekel MW; Denkers F; Wishaupt RG; Kummer JA; Snow GB; Brakenhoff RH
    Clin Cancer Res; 2000 Oct; 6(10):3803-16. PubMed ID: 11051222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular markers for diagnosis and prognosis.
    Partridge M; Gaballah K; Huang X
    Cancer Metastasis Rev; 2005 Jan; 24(1):71-85. PubMed ID: 15785873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Perspectives on the molecular epidemiology of aerodigestive tract cancers.
    Hung RJ; van der Hel O; Tavtigian SV; Brennan P; Boffetta P; Hashibe M
    Mutat Res; 2005 Dec; 592(1-2):102-18. PubMed ID: 16023150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic factors in head and neck oncology: a critical appraisal for use in clinical practice.
    Chiesa F; Tradati N; Mauri S; Calabrese L; Grigolato R; Giugliano G; Zurrida S; Chiesa E; Squadrelli M; Viale G; Maiorano E
    Anticancer Res; 1998; 18(6B):4769-76. PubMed ID: 9891555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biological agents in head and neck cancer.
    Bossi P; Locati LD; Licitra L
    Expert Rev Anticancer Ther; 2007 Nov; 7(11):1643-50. PubMed ID: 18020930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PET monitoring of therapy response in head and neck squamous cell carcinoma.
    Schöder H; Fury M; Lee N; Kraus D
    J Nucl Med; 2009 May; 50 Suppl 1():74S-88S. PubMed ID: 19380408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The effect of the microenvironment of head and neck cancers on tumor progression].
    Lukits J
    Magy Onkol; 2009 Mar; 53(1):51-9. PubMed ID: 19318327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oncogenes, molecular biology and the head and neck surgeon.
    Irish JC
    J Otolaryngol; 1992 Dec; 21 Suppl 3():1-20. PubMed ID: 1289578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Head and neck cancer: proteomic advances and biomarker achievements.
    Rezende TM; de Souza Freire M; Franco OL
    Cancer; 2010 Nov; 116(21):4914-25. PubMed ID: 20665484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Tumor markers used in the diagnosis, monitoring, treatment, and prognosis head and neck cancer].
    Kopczyński P; Flieger R
    Pol Merkur Lekarski; 2013 Jul; 35(205):37-8. PubMed ID: 23984603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hereditary and environmental factors associated with risk and progression of head and neck cancer.
    Trizna Z; Schantz SP
    Otolaryngol Clin North Am; 1992 Oct; 25(5):1089-103. PubMed ID: 1408193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The molecular marker eIF4E in the surgical margins of the resection preparations of head-neck tumors as a prognostic factor].
    Ernst-Stecken A
    Strahlenther Onkol; 2000 Aug; 176(8):383-4. PubMed ID: 10987024
    [No Abstract]   [Full Text] [Related]  

  • 17. Evolving 'omics' technologies for diagnostics of head and neck cancer.
    Nagaraj NS
    Brief Funct Genomic Proteomic; 2009 Jan; 8(1):49-59. PubMed ID: 19273537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early detection of head and neck cancer: development of a novel screening tool using multiplexed immunobead-based biomarker profiling.
    Linkov F; Lisovich A; Yurkovetsky Z; Marrangoni A; Velikokhatnaya L; Nolen B; Winans M; Bigbee W; Siegfried J; Lokshin A; Ferris RL
    Cancer Epidemiol Biomarkers Prev; 2007 Jan; 16(1):102-7. PubMed ID: 17220337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of clinically useful cancer prognostic factors: what are we missing?
    McShane LM; Altman DG; Sauerbrei W
    J Natl Cancer Inst; 2005 Jul; 97(14):1023-5. PubMed ID: 16030294
    [No Abstract]   [Full Text] [Related]  

  • 20. Molecular approaches to the staging of head and neck carcinomas (review).
    Gasparotto D; Maestro R
    Int J Oncol; 2007 Jul; 31(1):175-80. PubMed ID: 17549419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.